Enea TECH and Biomedical Foundation announces a ?15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer ...

Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis’ innovation lies in its integrated ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Guardant Health (GH) announced preliminary, unaudited results for the quarter and full year ended December 31, 2024. “2024 was an outstanding ...